Process for preparing stannic oxide hydrate
    61.
    发明授权
    Process for preparing stannic oxide hydrate 失效
    制备氧化锡水合物的方法

    公开(公告)号:US4041144A

    公开(公告)日:1977-08-09

    申请号:US575228

    申请日:1975-05-07

    CPC分类号: C01G19/02 C08K3/22

    摘要: A flame resisting agent to be incorporated into an aqueous spinning dope containing chlorine-containing polymer as a main polymer ingredient for improving the flame resistant property of the fiber spun from the spinning dope which includes a stannic oxide hydrate being substantially amorphous with respect to X-ray diffraction and having a bound water in the range of about 0.5 to about 0.7 mole of H.sub.2 O per 1 mole of SnO.sub.2. The flame resisting agent has a superior dispersibility in an aqueous spinning dope containing chlorine-containing polymer as a main polymer ingredient and the aqueous spinning dope in which the flame resisting agent is incorporated has a superior stability, filtering property and spinning property to give a uniform quality of fibers having a durable, superior flame resistant property.

    摘要翻译: 含有含氯聚合物作为主要聚合物成分的水性纺丝原液的阻燃剂,用于提高由纺丝原液纺丝的纤维的阻燃性,其包括相对于X射线的基本上无定形的氧化锡水合物, 并且每1摩尔SnO 2具有约0.5至约0.7摩尔H 2 O的结合水。 阻燃剂在含有含氯聚合物作为主要聚合物成分的水性纺丝原液中具有优异的分散性,并且其中引入阻燃剂的水性纺丝原液具有优异的稳定性,过滤性能和纺丝性能,使其均匀 纤维的质量具有耐用,优异的阻燃性能。

    Process for preparing 2-thioadenosine
    62.
    发明授权
    Process for preparing 2-thioadenosine 失效
    2-硫代腺嘌呤的制备方法

    公开(公告)号:US3989682A

    公开(公告)日:1976-11-02

    申请号:US595834

    申请日:1975-07-14

    IPC分类号: C07H19/16 C07H19/22

    CPC分类号: C07H19/16

    摘要: A process for preparing 2-thioadenosine, useful as an intermediate for the preparation of S-substituted-2-thioadenosines having a platelet aggregation inhibitory activity and a coronary vasodilating activity, which comprises reacting 5-amino-1-.beta.-D-ribofuranosylimidazole-4-carboxamide oxime or an O-substituted oxime thereof with carbon disulfide in a closed reaction zone at a temperature of from about 50.degree. to about 200.degree. C in a solvent.

    摘要翻译: 一种制备2-硫代腺嘌呤的方法,其可用作制备具有血小板聚集抑制活性和冠状血管扩张活性的S-取代-2-硫代腺嘌呤的中间体,其包括使5-氨基-1-β-呋喃核糖咪唑 - 4-羧酰胺肟或其O-取代的肟与二硫化碳在封闭反应区中在约50℃至约200℃的温度下在溶剂中反应。